# US 2006/0155118 A1 · Affinity purification system using troponin molecules as affinity ligands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0155118 A1
- Document ID: US20060155118A1
- Status: Published application
- Kind: A1
- Application number: 11/369,285
- Filed: 2006-03-06
- Published: 2006-07-13
- Earliest claimed: 2003-04-10
- Assignees: Aristex, Inc.
- Inventors: Randolph Moeckli; Christopher Chadwick
- Web page: https://patentgrep.com/patent/US20060155118A1

## CPC

- C12N 15/62: DNA sequences coding for fusion proteins
- C07K 14/47: from mammals
- C07K 14/4716: {Muscle proteins, e.g. myosin, actin}
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention pertains to the use of a novel set of tags for the immobilization and/or purification of proteins or other biological or organic molecules. The invention provides troponin C, troponin C binding peptide, and troponin I, or active fragments or analogues thereof as convenient tags and affinity ligands for immobilizing, attaching, or purifying proteins or other molecules. Methods for producing troponin-tagged molecules, such as recombinant fusion proteins, are described. Methods for preparing a troponin affinity matrix that is capable of specifically binding its cognate ligand in the presence of calcium, and methods for using such a matrix to purify troponin-tagged molecules are also described.

## Claims

### Claim at position 1

1: A method of purifying a troponin-tagged molecule, said method comprising contacting the troponin-tagged molecule with an affinity matrix that comprises a cognate ligand of the troponin tag, thereby immobilizing the troponin-tagged molecule on the affinity matrix.

### Claim at position 2 (depends on 1)

2: A method according to claim 1, wherein said troponin-tagged molecule is contacted with said affinity matrix in the presence of calcium.

### Claim at position 3 (depends on 2)

3: A method according to claim 2, wherein the affinity of binding between the troponin tag and said cognate ligand comprises a Kd greater than 10 nM.

### Claim at position 4 (depends on 2)

4: A method according to claim 2, wherein said troponin-tagged molecule is released from said affinity matrix by adding an agent that chelates calcium.

### Claim at position 5 (depends on 4)

5: A method according to claim 4, wherein said agent that chelates calcium is selected from the group consisting of EDTA, EGTA, BAPTA, citrate, and phosphate.

### Claim at position 6 (depends on 1)

6: A method according to claim 1, wherein said troponin-tagged molecule is a fusion protein that comprises a troponin molecule and a polypeptide that is not a troponin molecule.

### Claim at position 7 (depends on 6)

7: A method according to claim 6, wherein said fusion protein is produced recombinantly.

### Claim at position 8 (depends on 6)

8: A method according to claim 6, wherein said fusion protein comprises at least one troponin molecule at the N-terminus.

### Claim at position 9 (depends on 6)

9: A method according to claim 6, wherein said fusion protein comprises at least one troponin molecule at the C-terminus.

### Claim at position 10 (depends on 6)

10: A method according to claim 6, wherein said fusion protein comprises at least one troponin molecule at an amino acid residue between the N-terminus and the C-terminus.

### Claim at position 11 (depends on 6)

11: A method according to claim 6, wherein said fusion protein comprises a linker between said troponin molecule and said polypeptide that is not a troponin molecule.

### Claim at position 12 (depends on 11)

12: A method according to claim 11, wherein said linker is a polypeptide.

### Claim at position 13 (depends on 12)

13: A method according to claim 12, wherein said polypeptide linker comprises a protease recognition site.

### Claim at position 14 (depends on 13)

14: A method according to claim 13, wherein said polypeptide that is not a troponin molecule is released from said affinity matrix by protease cleavage at the protease recognition site.

### Claim at position 15 (depends on 1)

15: A method according to claim 1, wherein said troponin-tagged molecule comprises at least one molecule of troponin C, or a fragment or analogue thereof that is capable of specifically binding said cognate ligand on said affinity matrix.

### Claim at position 16 (depends on 15)

16: A method according to claim 15, wherein said affinity matrix comprises a troponin C binding peptide.

### Claim at position 17 (depends on 16)

17: A method according to claim 16, wherein said troponin C binding peptide comprises the sequence SRLDYLKSSLLHLGSR (SEQ ID NO: 1), or a fragment or analogue thereof that is capable of specifically binding troponin C.

### Claim at position 18 (depends on 17)

18: A method according to claim 17, wherein said troponin C binding peptide further comprises a cysteine residue at the N-terminus, and said affinity matrix is formed by reacting the troponin C binding peptide with a thiol reactive matrix.

### Claim at position 19 (depends on 16)

19: A method according to claim 16, wherein the affinity matrix comprises a substrate selected from the group consisting of cross-linked polysaccharide, agarose, ceramic, metal, glass, plastic, and cellulose.

### Claim at position 20 (depends on 16)

20: A method according to claim 16, wherein said troponin C-tagged molecule is released from said affinity matrix by adding a releasing agent, and wherein said releasing agent comprises a troponin C binding peptide.

### Claim at position 21

21-66. (canceled)
